Brinzolamide
11 NDCs across 5 manufacturers|8 Generic,3 Brand
Brinzolamide is used to treat open-angle glaucoma, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Apr 1, 1998, and the first generic was approved Nov 27, 2020. FDA's Orange Book lists 3 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $52 million on Brinzolamide across 224,000 claims for 66,000 beneficiaries.
Brinzolamide is available as 11 NDCs from 5 manufacturers (8 generic, 3 brand), with NADAC prices from $8.53 to $35.30 per ML — the most expensive product costs about 4.1× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
11
8G / 3B
Manufacturers
5
competing in market
Price Spread
$8.53 – $35.30
per ML
7d Activity
avg -6.0% WoW · of 11 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Sandoz Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Carbonic Anhydrase Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
5 manufacturers producing BRINZOLAMIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
AZOPT 1% EYE DROPS | $35.2980 per ML | +0.09% |
AZOPT 1% EYE DROPS | $35.1697 per ML | — |
AZOPT 1% EYE DROPS | $35.0627 per ML | -0.01% |
BRINZOLAMIDE 1% EYE DROPS | $12.5574 per ML | — |
BRINZOLAMIDE 1% EYE DROPS | $10.3789 per ML | — |
BRINZOLAMIDE 1% EYE DROPS | $9.4740 per ML | -6.00% |
BRINZOLAMIDE 1% EYE DROPS | $9.4740 per ML | -6.00% |
BRINZOLAMIDE 1% EYE DROPS | $9.4740 per ML | -6.00% |
BRINZOLAMIDE 1% EYE DROPS | $8.5264 per ML | -10.15% |
BRINZOLAMIDE 1% EYE DROPS | $8.5264 per ML | -10.15% |
BRINZOLAMIDE 1% EYE DROPS | $8.5264 per ML | -10.15% |
Frequently Asked Questions
What is Brinzolamide used to treat?
Brinzolamide is used to treat open-angle glaucoma, per the National Library of Medicine's MED-RT classification.
When did Brinzolamide become available as a generic?
FDA approved the first generic Brinzolamide (ANDA) on Nov 27, 2020. The Orange Book currently lists 3 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Brinzolamide?
In 2024, Medicare Part D spent $52 million on Brinzolamide across 224,000 claims for 66,000 beneficiaries.
How many Brinzolamide products are on the market?
The Brinzolamide drug market contains 11 NDCs from 5 manufacturers — 8 generic and 3 brand products.
What is the price range for Brinzolamide?
NADAC reference prices for Brinzolamide range from $8.5264 to $35.2980 per ML — the most expensive product costs about 4.1× the cheapest.
Is generic Brinzolamide cheaper than brand?
The average generic NADAC for Brinzolamide is $9.6172 per ML, versus $35.1768 for brand-labeled products — brand versions average about 3.7× the generic price.
Which manufacturers make Brinzolamide?
5 manufacturers list Brinzolamide in NADAC. Ranked by number of NDCs, the largest are Sandoz Inc. (4), Oceanside Pharmaceuticals (2), Bausch & Lomb Incorporated (2), Padagis US LLC (2), Novartis Pharmaceuticals Corporation (1).
How has the price of Brinzolamide changed recently?
Over the past 7 days, 1 Brinzolamide NDC rose and 7 fell, with a market-wide average change of -6.0%.